Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Etelcalcetide on Bone-tissue Properties and Calcification Propensity in End Stage Kidney Disease

NCT03960437 is registered in ClinicalTrials.gov with Thomas Nickolas, MD MS as lead sponsor.

NCT NCT03960437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03960437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Etelcalcetide on Bone-tissue Properties and Calcification Propensity in End Stage Kidney Disease
Lead sponsor
Thomas Nickolas, MD MS
Phase
Phase 2
Overall status
Completed
Start date
September 6, 2018
Completion date
November 19, 2020
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease mineral and bone disorder, hyperparathyroidism; secondary, renal, renal osteodystrophy, vascular calcification